Overcoming Challenges in Preclinical Gene Therapy Testing for Neurological Diseases
Watch this webinar to learn how JAX leverages validated models of neurodegenerative and neurodevelopmental disease to evaluate biodistribution, efficacy, and target engagement.
Watch Video